Skip to content
Open access

The Additional Role of the Quantitative Measurements of 18F-FDG PEM Compared to PET/CT in the Evaluation of Post Interventional Breast Neoplasm

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations · 15 references

TL;DR

PEM offers superior spatial resolution and provides complementary metabolic information to PET/CT, particularly in small or multifocal lesions, particularly in small or multifocal lesions.

Abstract

Background: Breast cancer remains the most frequent malignancy between females globally. Accurate post-interventional assessment is essential for determining disease extent and guiding management. This research aimed to measure the additional role of quantitative measurements of 18F-FDG positron emission mammography (PEM) compared to 18F-FDG positron emission tomography/computed tomography (PET/CT) in assessing post-interventional breast neoplasms. Methods: This prospective research was conducted on 36 female cases with pathologically proven breast cancer between December 2022 and April 2024. All cases had both 18F-FDG PET/CT and PEM on the same day. Semi-quantitative parameters, including SUVmax, PUVmax, and lesion-to-background (LTB) ratio, have been calculated and compared. Correlation analyses were performed, and changes in risk classification and management intent were assessed. Results: PEM detected 42 lesions, while PET/CT detected 43. Three lesions (7.1%) were detected only by PEM—all approximately 1 cm—while four lesions (9.3%) were missed by PEM. The mean PUVmax was 6.3 ± 4.1, and the mean LTB was 6.2 ± 4.3. SUVmax illustrated a strong positive association with PUVmax (r value equal to 0.866, p value below 0.001). Risk stratification changed in 10 patients (27.7%) after incorporating PEM findings, with 6 lesions upgraded and 4 downgraded, directly affecting management decisions. Conclusion: PEM offers superior spatial resolution and provides complementary metabolic information to PET/CT, particularly in small or multifocal lesions. Quantitative PEM indices enhance diagnostic accuracy and can significantly influence post-interventional breast cancer management.

Read PDF

Similar papers

Oct 2026

Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus.

This study aimed to evaluate the clinical value of fluorine-18-labeled fluorodeoxyglucose (18F-FDG) PET/computed tomography (CT) in managing primary malignant melanoma of the esophagus (PMME). Seventy patients with pathologically confirmed PMME between September 2011 and June 2025 were retrospectively analyzed. The dia...

Fei Wang, Xiang-Xi Meng, R. Guo et al. · 0 citations
Open access Oct 2026

From staging to changing strategy: [18F]FDG PET/MRI's impact on treatment planning in early breast cancer.

MRI was highly informative for detecting multifocal disease, whereas the potential added value of [18F]FDG PET/MRI may primarily relate to integrated axillary and distant staging, however, its moderate diagnostic accuracy warrants caution to prevent overtreatment.

R. di Micco, S. P. Corona, V. Bagnardi et al. · 0 citations
Review Open access Oct 2026

Is 18 F-FDG PET/CT Necessary During Vismodegib Therapy for Basal Cell Carcinoma? Quantitative Changes and Incremental Value Beyond CT

Abstract Objectives The role of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in monitoring basal cell carcinoma (BCC) during vismodegib therapy remains poorly defined, particularly in patients with extensive, multifocal, or Gorlin syndrome–associated disease. This study ai...

S. Bilgiç, Çağla Karaoğlu, Elif İşleyen Çolak et al. · 0 citations
Open access Oct 2026

Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study

Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion.

B. Saylam, Berfin Temelli, Ali Nebi̇oğlu et al. · 0 citations
Open access Oct 2026

Accuracy of positron emission mammography for tumor size assessment and detection of other breast lesions in newly diagnosed breast cancer

Positron emission mammography (PEM) is a valuable tool for assessing the extent of disease in newly diagnosed breast cancer patients, particularly among women pursuing conservative surgical management. The aim of this study was to evaluate the added diagnostic value of preoperative Positron Emission Mammography (PEM) i...

E. Kamal, Mahmoud Mekhaimar, R. Hamid et al. · 0 citations
Sep 2026

Optimization of Positron Emission Tomography Computed Tomography Using 68Ga-FAPI in the Diagnosis of Colorectal Cancer Metastases and Monitoring of Antitumor Treatment Efficacy

PET/CT using 68Ga-FAPI is a promising imaging modality for colorectal cancer, allowing detection of metastatic and additional suspicious lesions and assessment of dynamic changes during antitumor treatment.

Madina Altinbekova, T. Dautov, Z. Kozhakhmetova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.